FDA Recall Open, Classified

PALMAZ GENESIS Transhepatic Biliary Stent on OPTA PRO .035" Delivery System, Catalog numbers PG2990BPS, PG2990BPX, PG3990BPS, PG3990BPX.

Recall: Z-1363-2022 · Initiated May 20, 2022

Recall

Recall Number
Z-1363-2022
Event Number
90253
Firm
Cordis US Corp
FEI Number
1016427
Product Code
FGE
Status
Open, Classified
Root Cause
Process design
Initiated
May 20, 2022
Address
14201 Nw 60th Ave, Miami Lakes, FL, 33014-2802

Description

PALMAZ GENESIS Transhepatic Biliary Stent on OPTA PRO .035" Delivery System, Catalog numbers PG2990BPS, PG2990BPX, PG3990BPS, PG3990BPX.

Reason

Potential for stent dislodgement and associated failures related to two specific sizes of the device.

Action

The recalling firm issued letters dated 5/16/2022 on 5/20/2022 via FedEx to the U.S. customers. The letter explained the issue, provided details on the affected device to assist in the identification of the product involved, and requested the consignee immediately check their inventory for the affected product and quarantine it. An Acknowledgment Form was enclosed for completion and return to the recalling firm. The consignee was to share the letter with others in their facility who need to be made aware of the recall and with any other facility that may have been sent the affected units.

Distribution

US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, WA, WI, and WY. There was also government/military distribution.

Quantity

1,089 units